Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $89.4303 (1.01%) ($87.8629 - $89.6045) on Thu. Jun. 28, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.8% (three month average) | RSI | 22 | Latest Price | $89.4303(1.01%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.7% a day on average for past five trading days. | Weekly Trend | ABBV declines -3.5% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(61%) VYM(50%) IVE(49%) IWD(48%) SPLV(48%) | Factors Impacting ABBV price | ABBV will decline at least -0.9% in a week (0% probabilities). VIXM(-14%) TLT(-14%) VXX(-13%) UUP(-11%) DIA(-9%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.9% (StdDev 1.8%) | Hourly BBV | 0 () | Intraday Trend | 1.2% | | | |
|
1 - 5 Day Possible Target | $85.38(-4.53%) | Resistance Level | $93.88 | 5 Day Moving Average | $89.52(-0.1%) | 10 Day Moving Average | $91.98(-2.77%) | 20 Day Moving Average | $93.88(-4.74%) | To recent high | -13% | To recent low | 4% | Market Cap | $157.78b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |